Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Research
Research
First Bundibugyo Ebola vaccine to enter phase 1 trials
The ChAdOx1 BDBV vaccine uses the same platform as the AstraZeneca COVID-19 vaccine.
Marissa Russo
Jul 14, 2026 12:18pm
Merck KGaA in-office requirement could lead to 70 US layoffs
Jul 13, 2026 2:32pm
ARPA-H awards up to $160M for custom genetic medicines
Jul 10, 2026 4:00am
Fate’s CAR-T prospect shows early promise in systemic sclerosis
Jul 9, 2026 10:24am
China approved the first solid tumor CAR-T. Will the US follow?
Jun 30, 2026 10:00am
BioCryst ends internal programs in pivot to partnerships
Jun 29, 2026 10:30am